Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2012

Feb 3, 2012

32939_dirs_2012-02-03_60058ba7-e373-426c-91a6-596fe1b5ff6a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2012-02-02

Reporting Person: Kapusta Matthew C (SVP, Business Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-02-02 Common Stock A 15000 Acquired 15000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-02-02 Non-Qualified Stock Option (right to buy) $12.82 A 80000 Acquired 2018-11-15 Common Stock (80000) Direct

Footnotes

F1: The acquisition of 15,000 shares of common stock represents 15,000 restricted stock units, each of which represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The restricted stock units vest in four equal annual installments beginning on 11/15/2012.

F2: Options for 25% of the shares are each exercisable on 11/15/2012, 11/15/2013, 11/15/2014 and 11/15/2015, respectively